Melanoma

Featuring:
Dr. Ralph Wong

Melanoma

Featuring:
Dr. Parneet Cheema

PD1 Blockage in Kaposi Sarcoma

Non-Melanoma Skin Cancer
Featuring:
Dr. Marcus Butler
Dr. Michael Smylie
Dr. Jason Luke

Local Therapy in Solitary Melanoma, NIVO+IPI vs NIVO and ILLUMINATE-204

Metastatic/Advanced Melanoma
Featuring:
Dr. Marcus Butler
Dr. Michael Smylie
Dr. Jason Luke

KEYNOTE 054 and CheckMate 238

Adjuvant Trials in Melanoma
Featuring:
Dr. Marcus Butler
Dr. Michael Smylie
Dr. Jason Luke

COMBI-i Trial, LEAP-004 and SECOMBIT

Metastatic/Advanced Melanoma
Featuring:
Dr. Marcus Butler
Dr. Michael Smylie
Dr. Jason Luke

A multi-disciplinary approach to the evolving landscape of advanced cSCC

Featuring:
Dr. Scott Ernst
Dr. Ian Poon
Dr. Kathryn Roth
Dr. David Zloty

SECOMBIT Study

Featuring:
Dr. Paolo Ascierto

4-year recurrence-free and OS results from CheckMate 238

Featuring:
Dr. Jeffrey Weber

Melanoma

Featuring:
Dr. Jose Monzon

Melanoma

Featuring:
Dr. Marcus Butler

Melanoma

Featuring:
Dr. Scott Ernst

LN-144

Advanced Melanoma

Featuring:
Dr. Michael Smylie
Dr. Marcus Butler
Dr. Jason Luke

PRADO (Follow up of OpACIN-neo)

Neoadjuvant Melanoma

Featuring:
Dr. Michael Smylie
Dr. Marcus Butler
Dr. Jason Luke

LOW-DOSE IPI + PEMBRO IN MEL

Advanced Melanoma

Featuring:
Dr. Michael Smylie
Dr. Marcus Butler
Dr. Jason Luke

KEYNOTE-006

Advanced Melanoma

Featuring:
Dr. Michael Smylie
Dr. Marcus Butler
Dr. Jason Luke

COMBI-AD & EORTC 1325-MG/KEYNOTE 054

Adjuvant Melanoma

Featuring:
Dr. Michael Smylie
Dr. Marcus Butler
Dr. Jason Luke

COMBO IMMUNOTHERAPY (NIVOLIMAB + IPILUMAB)

Metastatic Melanoma

Featuring:
Dr. Michael Smylie
Dr. Marcus Butler
Dr. Jason Luke

ASCO20 Virtual Data Watch - Melanoma

The Future of Melanoma Therapy

Featuring:
Dr. Caroline Robert

Current Systemic Approach in Poor Prognostic Advance Melanoma

Featuring:
Dr. Paul Lorigan

Managing Endocrine IO Toxicities

Featuring:
Dr. Sabrina Gill

Dermatological Complications of Targeted and IO Therapy

Featuring:
Dr. Maxwell Sauder

Treatment and Prevention of Melanoma: The Way Forward with Lessons from the Past

Featuring:
Dr. Ian Quirt

Follow up Guidelines

Featuring:
Dr. Noelle Davis

Interactive Discussion, the Pros and Cons of Neoadjuvant Therapy

Featuring:
Dr. Georgina Long
Dr. Merrick Ross

Symposium: Optimizing the Multi-Disciplinary Management of Patients with BRAF + Melanoma

Featuring:
Dr. Caroline Robert
Dr. Wilson Miller
Dr. Merrick Ross
Dr. Brandon Sheffield
Dr. Joel Claveau

Neoadjuvant Therapy: The Medical and Surgical Oncology Approach

Featuring:
Dr. Georgina Long
Dr. Merrick Ross

Neoadjuvant Therapy: The Medical and Surgical Oncology Approach - Part 1

Featuring:
Dr. Georgina Long

Neoadjuvant Therapy: The Medical and Surgical Oncology Approach - Part 2

Featuring:
Dr. Merrick Ross

Symposium: Advanced Melanoma: Long Term Survival, Brain Metastasis and Adjuvant Therapies

Featuring:
Dr. Joel Claveau
Dr. Georgina Long
Dr. Scott Ernst

Cardiac Toxicity with Melanoma Therapy

Featuring:
Dr. Dinesh Thavendiranathan

Classification of Melanoma: The Updated WHO Classification and Beyond

Featuring:
Dr. Boris Bastian

Biomarkers in Immunotherapy

Featuring:
Dr. Keith T. Flaherty

Head and Neck Melanoma

Featuring:
Dr. David Goldstein

Clinical Pathological Case Presentation

Featuring:
Dr. Scott Ernst
Dr. Joel Claveau
Dr. Margaret Redpath

Symposium: Management of Advanced Squamous Cell Carcinoma

Featuring:
Dr. Michael Migden
Dr. David Zloty
Dr. Joel Claveau

New Insights in the Epidemiology of Melanoma

Featuring:
Dr. Ivan Litvinov

Gut Microbiome and Melanoma: Are We Ready for Clinical Trials in Canada?

Featuring:
Dr. Arielle Elkrief

Symposium: Immunotherapy In Melanoma: Where Are We

Featuring:
Dr. Caroline Robert
Dr. Teresa Petrella
Dr. Michael Smylie

Address from Melanoma Network

Featuring:
Annette Cyr

Melanoma

Featuring:
Dr. Vanessa Bernstein

CheckMate 238 Trial

Featuring:
Dr. Jeffrey Weber

ABC Trial

Featuring:
Dr. Georgina Long

Melanoma

Featuring:
Dr. Jose Monzon

Melanoma

Featuring:
Dr. Parneet Cheema

Melanoma

Featuring:
Dr. Wilson Miller

Management and Treatment of Advanced Squamous Cell Carcinoma

Sponsored by Sanofi - Genzyme

Drug Funding Challenges

Featuring: Bill Dempster

Current Advances and Future Directions in Cutaneous Squamous Cell Carcinoma

Sponsored by Sanofi-Genzyme

Interactive Case-Based Discussion of Patients with High-Risk Melanomas

Sponsored by BMS

Adjuvant Therapy

Featuring:
Dr. Paul Lorigan

Metastatic Disease

Featuring:
Dr. Paul Lorigan 

Biomarker Response

Featuring:
Dr. Paul Lorigan

Q+A and Case Presentations

Featuring:
Dr. Paul Lorigan

The Role of the Orthopedic Surgeon in a Multidisciplinary Melanoma Team

Featuring: Dr. Annie Arteau

Microbiome and the Implications to Immunotherapy

Featuring: Dr. Karen Masden

Establishing Surveillance Guidelines for Stage 2 and Stage 3 Melanoma Patients

Featuring: Dr. Noelle Davis

Unusual Complications of Immunotherapy

Featuring: Dr. Marcus Butler & Dr. Wilson Miller

Sequencing of Therapy: A Case Based Presentation

Sponsored by Novartis

Dermatological Complications of Targeted Therapy and Immunotherapy

Featuring: Dr. Mario Lacouture

Updates in Adjuvant Therapy

Featuring:
Dr. Axel Hauschild

Achieving the Best Outcomes in Metastatic Melanoma

Sponsored by Merck

Brain Metastases Panel Discussion

Featuring:
Dr. Teresa Petrella (Chair) & Dr. Sten Myrehaug

Immunotherapy Combinations

Featuring:
Dr. Jeffrey Weber

Dermatopathology Pearls in Melanoma and other skin cancers

Featuring:
Dr. Joël Claveau & Dr. Sébastien Labonté

Case Conference

Featuring:
Dr. Joël Claveau, Dr. Scott Ernst & Dr. Sébastien Labonté

Established and Emerging Biomarkers in Melanoma

Featuring:
Dr. Ryan Sullivan

Remarks from Not-For-Profit

Featuring:
Kathy Bernard & Dr. Scott Ernst

Management of Micro and Macro Node Positive Disease

Featuring:
Dr. Vernon Sondak

Molecular Genetics Overview

Featuring:
Dr. Hensin Tsao

Melanoma

Featuring:
Dr. Ralph Wong

Best of Oncology East 2018 - Melanoma

Featuring:
Dr. Teresa Petrella

Clinical Evidence for Immuno-Therapies in Practice in Melanoma

Featuring:
Dr. Teresa Petrella

OpACIN-neo Trial

Featuring:
Dr Marcus Butler
Dr Jeffrey weber

Updates in Advanced Melanoma

Featuring:
Dr Marcus Butler
Dr Jeffrey weber

OpACIN-neo Trial

Featuring:
Dr. Lissette Rozeman

Best of ASCO Vancouver 2018 - Melanoma

Featuring:
Dr. Michael Smylie

Best of ASCO Toronto 2018 - Melanoma

Featuring:
Dr. Teresa Petrella

Validation of the 8th AJCC Melanoma Staging System on Outcomes

Featuring:
Dr. Max Madu

CheckMate 238 Trial Update

Featuring:
Dr. Jeffrey Weber

Updates in Adjuvant Therapy

Dr. Marcus Butler
Dr. John Walker
Dr. Jason Luke

Updates in Metastatic Melanoma

Dr. Marcus Butler
Dr. John Walker
Dr. Jason Luke

Efficacy & Safety IMO 2125 with IPI in PD-1 Inhibitor Refractory Melanoma

Featuring:
Dr. Adi Diab

Updates in Systemic Therapy for Other Skin Cancers

Dr. Marcus Butler
Dr. John Walker
Dr. Jason Luke

Treatment Post-PD-1 Progression

Dr. Marcus Butler
Dr. John Walker
Dr. Jason Luke

What's next for Melanoma?

Dr. Marcus Butler
Dr. John Walker
Dr. Jason Luke

Question & Answer Period

Featuring:
Dr. David Hogg

Introduction, Etiology & Epidemiology

Featuring:
Dr. David Hogg

Pathology, Work-Up & Staging

Featuring:
Dr. David Hogg

Management of Primary Disease: Surgery & Radiotherapy & Systemic Therapy

Featuring:
Dr. David Hogg

Checkpoint Inhibitors in Merkel cell carcinoma

Featuring:
Dr. David Hogg

Le mélanome métastatique

Avec:
Dr. Caroline Robert

Le mécanisme des facteurs eIF4 et du ligand PDL1 dans le traitement du mélanome

Avec:
Dr. Caroline Robert

Le traitement adjuvant du mélanome

Avec:
Dr. Caroline Robert

Discussion de cas et période de questions

Avec:
Dr. Caroline Robert

L’immunothérapie du mélanome

Avec:
Dr. Caroline Robert

Case Discussion & Question Period

Featuring:
Dr. Caroline Robert

Adjuvant Treatment in Melanoma

Featuring:
Dr. Caroline Robert

Mechanism of EIF4 and PDL1 in Melanoma Treatment

Featuring:
Dr. Caroline Robert

Metastatic Melanoma

Featuring:
Dr. Caroline Robert

Immunotherapy in Melanoma

Featuring:
Dr. Caroline Robert

Driver Mutations in Melanoma: Creating a Framework for Targeted and Immune Therapy

Featuring:
Dr. Ian Watson

Predictive Immunological Markers

Featuring:
Dr. Phil Halloran

Targeted Therapy & BRAF Testing - Advancements in Adjuvant Melanoma

Featuring:
Professor Grant McArthur & Dr. Michael Smylie

Adjuvant Treatment of High Risk Melanoma

Featuring:
Dr. Jason Luke

Medical Oncology/Surgical Joint Session: Neoadjuvant Therapy

Featuring:
Dr. Merrick Ross & Dr. Teresa Petrella

Health Economics Update in Melanoma

Featuring:
Dr. Nicole Look Hong & Dr. Stuart Peacock

Use of IO-IO Combination in the Treatment of Melanoma

Featuring:
Dr. Jason Luke, Professor Reinhard Dummer, Dr. Michael Smylie

Update on Intralesional Therapy

Featuring:
Dr. Robert Andtbacka

New AJCC Classification: What's in & What's out?

Featuring:
Dr. Charles Balch

Molecular Resistance to Targeted Therapy

Featuring:
Professor Grant McArthur

Immuno-Intervention in Patients with Merkel Cell Carcinoma

Featuring:
Dr. Paul Ngheim & Dr. David Hogg

Debate: Completion Node Dissection vs Observation Post-MSLT-II Trial Results

Featuring:
Dr. Charles Balch vs. Dr. Carman Giacamantonio

Novel Targeted Agents and Drug Combinations

Featuring:
Prof. Reinhard Dummer

Medicolegal Problems in Melanoma

Featuring:
Dr. Steven Bellemare, Dr. David Hogg, Dr. Scott Ernst, Dr. Joel Claveau & Dr. Sebastien Labonte

Optimal Sequencing of Therapy in Metastatic Melanoma

Featuring:
Dr. Joel Claveau, Dr. David Hogg & Dr. Vanessa Bernstein

Medical Oncology: Pseudoprogession Treatment Beyond Progression, and Melanoma Mimics

Featuring:
Dr. David Hogg

Overcoming Resistance to Immunotherapy

Featuring:
Dr. Antoni Ribas

Difficult to Diagnose Melanomas

Featuring:
Dr. Ashfaq Marghoob

Best of Oncology East 2017 - Melanoma

Featuring:
Dr. Parneet Cheema

Best of Oncology West 2018 - Melanoma

Featuring:
Dr. Jose Monzon

Video 1: Advances in Metastatic Melanoma

Featuring:
Dr. Jason Luke
Dr. Teresa Petrella
Dr. Michael Smylie

Video 2: Advances in BRAF Targeted and Immunotherapy Agents in Adjuvant Melanoma

Featuring:
Dr. Jason Luke
Dr. Teresa Petrella
Dr. Michael Smylie

Video 3: Advances in the Neoadjuvant Setting

Featuring:
Dr. Jason Luke
Dr. Teresa Petrella
Dr. Michael Smylie

CheckMate 238

Featuring:
Dr. Jeffrey Weber

ECHO-202/KEYNOTE-037

Featuring:
Dr. Omid Hamid

Upcoming Cell Therapy & Immunotherapy Trials: What's Being Conducted in Canada - Dr. Miller

Featuring:
Dr. Wilson Miller

Key Updates in Melanoma

Featuring:
Dr. Georgina Long

COMBI-MB Trial

Featuring:
Michael A. Davies

Key Updates in Melanoma

Featuring:
Dr. Vanessa Bernstein

Best of ASCO Toronto 2017 - Melanoma

Featuring:
Dr. David Hogg

Best of ASCO Montreal 2017 - Melanoma

Featuring:
Dr. Marcus Butler

Best of ASCO Vancouver 2017 - Melanoma

Featuring:
Dr. Vanessa Bernstein

Best of Oncology West 2016 - Melanoma

Featuring:
Dr. John Walker

Evolution of Molecular Diagnostics in 2017

Featuring:
Dr. Boris Bastian

Sequencing of Targeted & Immunotherapy

Featuring:
Dr. Keith Flaherty

Predictive/Prognostic Immunological Factors Confirmed and Potential

Featuring:
Dr. Antoni Ribas

Immune Check Point Inhibitors: What It Is and What Is to Come

Featuring:
Dr. Jason Luke

Lunch Symposium: Zeroing in on BRAF Targeted Therapy

Featuring:
Dr. Jason Luke
Dr. Marcus Butler
Dr. Tara Baetz

Evolving Role of Surgery in the Immunotherapy Era/Management of Complex Situations

Featuring:
Dr. Merrick Ross

Re-thinking Adjuvant Therapy

Featuring:
Dr. Axel Hauschild

Lunch Symposium: Difficult-To-Treat Subtypes of Melanoma: What Role Does Immunotherapy Play?

Featuring: Dr. Antoni Ribas
Dr. Keith Flaherty
Dr. Michael Smylie

Merkel Cell Carcinoma Management Re-visited - Surgery/Radiation

Featuring:
Dr. Vernon Sondak

Merkel Cell Carcinoma Management Re-visited - Systemic Therapy

Featuring:
Dr. Marcus Butler

Merkel Cell Carcinoma Management Re-visited - Question & Answer Session

Featuring:
Dr. Joël Claveau
Dr. Vernon Sondak
Dr. Marcus Butler

CTLA-4 and PD-1 Inhibitor Combinations

Featuring:
Dr. Michael Postow

Patient and Physician Input to Health Technology Assessments in 2017: Insights for Success

Featuring:
Mr. Barry Stein

Upcoming Cell Therapy & Immunotherapy Trials: What's Being Conducted in Canada - Dr. Butler

Featuring:
Dr. Marcus Butler

Making the Right Choices for Patients: Combination Therapy in the Canada

Featuring: Dr. Axel Hauschild
Dr. Jeffrey Weber
Dr. Michael Smylie
Dr. Joël Claveau

Immune Therapy and Auto-Immune Disease

Featuring:
Dr. Jeffrey Weber

Health Economics Surrounding Management of Melanoma in Canada - Dr. Mittman

Featuring:
Dr. Nicole Mittmann

Health Economics Surrounding Management of Melanoma in Canada - Dr. Look Hong

Featuring:
Dr. Nicole Look Hong

Health Economics Surrounding Management of Melanoma in Canada - Dr. Peacock

Featuring:
Dr. Stuart Peacock

Health Economics Surrounding Management of Melanoma in Canada - Dr. de Oliveira

Featuring:
Dr. Claire de Oliveira

Health Economics Surrounding Management of Melanoma in Canada - Question and Answer

Featuring:
Dr. Nicole Mittmann
Dr. Nicole Look Hong
Dr. Stuart Peacock
Dr. Claire de Oliveira

Best of Oncology East 2016 - Melanoma

Featuring:
Dr. David Hogg

TcR Sequencing Analysis & Neo-Antigen Load Associated in Melanoma

Featuring:
Dr. Jeffrey Weber

Challenges in access to new life-saving drugs in Europe

Featuring:
Dr. Lidija Kandolf-Sekulovi

OpACIN Trial

Featuring:
Dr. Christian Blank

KEYNOTE-002 trial

Featuring:
Dr. Omid Hamid

EORTC 18071 Phase III Trial

Featuring:
Dr. Ralph Wong

Skin Cancers Highlights

Featuring:
Dr. David Hogg

Best of ASCO Vancouver 2016 - Melanoma

Featuring:
Dr. Jose Monzon

Melanoma Updates: Expert Opinion

Featuring:
Dr. Jason Luke
Dr. Teresa Petrella
June 29th, 2016

Role of Predictive Biomarkers in Melanoma

Featuring:
Dr. Jason Luke
Dr. Teresa Petrella

Technologies for PD-L1 Testing in Melanoma

Featuring:
Dr. Jason Luke
Dr. Teresa Petrella

Approaches to Treating Metastatic Melanoma - Patients with BRAF Mutant vs WT

Featuring:
Dr. Jason Luke
Dr. Teresa Petrella

Monotherapy vs Combination Therapy – Patient Selection

Featuring:
Dr. Jason Luke
Dr. Teresa Petrella

Sequencing Targeted Therapy and Immunotherapy

Featuring:
Dr. Jason Luke
Dr. Teresa Petrella

Rechallenging and Retreatment

Featuring:
Dr. Jason Luke
Dr. Teresa Petrella

Future Developments in Patient Therapy (Including Adjuvant Therapy)

Featuring:
Dr. Jason Luke
Dr. Teresa Petrella

Managing Adverse Events

Featuring:
Dr. Jason Luke
Dr. Teresa Petrella

Adverse Events Associated with Melanoma

Featuring:
Dr. Caroline Robert
Dr. Marcus Butler

New Technologies in the Diagnosis of Melanoma

Featuring:
Dr. Caroline Robert
Dr. Marcus Butler

Role of Predictive Biomarkers in Melanoma

Featuring:
Dr. Caroline Robert
Dr. Marcus Butler

Role of Anti-PD-L1 and Immunotherapy in Melanoma

Featuring:
Dr. Caroline Robert
Dr. Marcus Butler

Approach to Treating Advanced or Metastatic Melanoma: Patient Selection and Agent Use

Featuring:
Dr. Caroline Robert
Dr. Marcus Butler

Approach to Treating Advanced or Metastatic Melanoma: Treatment After Progression with Targeted Agents

Featuring:
Dr. Caroline Robert
Dr. Marcus Butler

The Future of Targeted Therapy in Melanoma

Featuring:
Dr. Caroline Robert
Dr. Marcus Butler

Adjuvant Therapy in Melanoma

Featuring:
Dr. Caroline Robert
Dr. Marcus Butler

Melanoma Updates: Expert Opinion

Featuring:
Dr. Caroline Robert
Dr. Marcus Butler
June, 2016

Best of ASCO Toronto 2016 - Melanoma

Featuring:
Dr. David Hogg

Best of ASCO Montreal 2016 - Melanoma

Featuring:
Dr. Marcus Butler

Updates from Chicago 2016: Melanoma

Featuring:
Dr. Antonio Buzaid

Question 2

Featuring:
Dr. Wilson Miller

Question 3

Featuring:
Dr. Wilson Miller

Question 5

Featuring:
Dr Wilson Miller

Abstract Presentation: Efficacy and Safety of Nivolumab

Featuring:
Dr. Carrie Savage

Abstract Presentation: Toxicity of High-Dose Interferon for High-Risk Melanoma in Ontario

Featuring:
Dr. Timothy Hanna

Dinner Symposium: Optimizing Survival in BRAF V600-Mutated Advanced Melanoma

Featuring:
Dr. Wilson Miller
Dr. Alan Spatz
Dr. Joel Claveau

Breakfast Symposium: Patient Management Considerations with PD-1 Inhibitors

Featuring:
Dr. Antoni Ribas
Dr. Marcus Butler
Dr. Michael Smylie

Revelations from the Canadian Melanoma Research Network

Featuring:
Dr. Scott Ernst

Immune Checkpoint Inhibitors Revolution

Featuring:
Dr. Axel Hauschild

Debate: Role of SLNB in Thick Melanomas

Featuring:
Dr. Merrick Ross
Dr. Greg Mckinnon

Challenging Cases for Pathologists and Surgeons

Featuring:
Dr. Alan Spatz
Dr. Martin Trotter
Dr. Claire Temple-Oberle

Management of Brain Metastases

Featuring:
Dr. Teresa Petrella
Dr. Sten Myrehaug

Tumour Heterogeneity in Melanoma

Featuring:
Dr. David Polsky

Adjuvant Therapy for High Risk Melanoma

Featuring:
Dr. Axel Hauschild

Combination Therapies: What Make Sense and What is to Come

Featuring:
Dr. Keith Flaherty

Epidemiology of Melanoma in Canada

Featuring:
Dr. Thomas Salopek

Response and Resistance to PD-1 Blockade

Featuring:
Dr. Antoni Ribas

Workshop: Dermoscopy for the Non-Dermatologist

Featuring:
Dr. Joel Claveau
Dr. Harold Rabinovitz
Ms. Margaret Olivero

New Approaches to Diagnosis

Featuring:
Dr. Harold Rabinovitz

Head and Neck Melanoma Management

Featuring:
Dr. Vernon Sondak

Emerging Role of Surgery in Immunotherapy Era

Featuring:
Dr. Vernon Sondak

Abstract Presentation: Topical Immunotherapy with Diphencyprone

Featuring:
Dr. Carrie Yeung

Abstract Presentation: Epidemiology of Pediatric Melanoma in Canada

Featuring:
Dr. Paul Kuzel

Genetic Evolution of Melanoma from Precursor Lesions

Featuring:
Dr. Boris Bastian

Molecular Pathology of Melanoma in the Clinical Setting

Featuring:
Dr. Alan Spatz

Best of Oncology West 2017 - Melanoma

Featuring:
Dr. Ralph Wong

Question 5 (en français)

Featuring:
Dr. Joël Claveau

Question 4 (en français)

Featuring:
Dr. Joël Claveau

Question 2 (en français)

Featuring:
Dr. Joël Claveau

Question 3 (en français)

Featuring:
Dr. Joël Claveau

Question 1 (en français)

Featuring:
Dr. Joël Claveau

Question 5

Featuring:
Dr. Ralph Wong

Question 4

Featuring:
Dr. Ralph Wong

Question 3

Featuring:
Dr. Ralph Wong

Question 1

Featuring:
Dr. Ralph Wong

Question 2

Featuring:
Dr. Ralph Wong

Question 1

Featuring:
Dr. Wilson Miller

Question 5

Featuring:
Dr. Winson Cheung

Question 4

Featuring:
Dr. Winson Cheung

Question 3

Featuring:
Dr. Winson Cheung

Question 1

Featuring:
Dr. Winson Cheung

Question 2

Featuring:
Dr. Winson Cheung

Question 5 (English)

Featuring:
Dr. Joël Claveau

Question 4 (English)

Featuring:
Dr. Joël Claveau

Question 2 (English)

Featuring:
Dr. Joël Claveau

Question 3 (English)

Featuring:
Dr. Joël Claveau

Question 1 (English)

Featuring:
Dr. Joël Claveau

An Expert's Perspective on BRAF V600-Mutated Advanced Melanoma

Featuring:
Dr. Keith Flaherty

Integrating New Treatment Options for Melanoma

Featuring:
Dr. Keith Flaherty,

Integrating New Treatment Options For Melanoma

Featuring:
Dr. Keith Flaherty

Addressing Key Questions in Immuno-Oncology

Featuring:
Dr. David Hogg
Dr. Xinni Song

Clinical and Therapeutic Significance of the PI3K-AKT Pathway in Melanoma

Featuring:
Dr. Michael A. Davies

The Rate of Missed Melanoma in Sentinel Node Negative Patients

Featuring:
Dr. Chloé E. Ward

Bad Basals and Scary Squams: Managing the Advanced Non-Melanoma Skin Cancers

Featuring:
Dr. David Hogg

A 7-yr Analysis of Mitotic Rate and Sentinel Lymph Node Biopsy

Featuring:
Dr. Heidi Wat

PD1 Therapy and Biomarkers for Response

Featuring:
Dr. Omid Hamid

Do We Really Need Big Data? Subtext - Is It Better to Know the "Why" Rather than the "What"?

Featuring:
Dr. Femida Gwadry-Sridhar

Immunotherapy for All: Next Steps When Current Therapies Fail

Featuring:
Dr. Marcus Butler

Mohs Surgery for Melanoma and Merkel; Helpful, Hurtful or Hapless?

Featuring:
Dr. David M. Zloty

Diagnostic Advances in Melanoma Detection

Featuring:
Dr. Jason K. Rivers

Clinical Outcomes Following Pulmonary Metastatectomy for Melanoma

Featuring:
Carl Chauvin

Adjuvant Melanoma Treatment: Past, Present and Future

Featuring:
Dr. Axel Hauschild

Identifying T Cell-Mediated Inflammation in Tissue by Molecular Phenotyping

Featuring:
Dr. Philip Halloran

Best of ASCO Montreal 2017 - Melanoma

Featuring:
Dr. Marcus Butler

Melanoma Updates: Expert Opinion

Featuring:
Dr. Jason Luke
Dr. Teresa Petrella
June 29th, 2016

Melanoma Updates: Expert Opinion

Featuring:
Dr. Caroline Robert
Dr. Marcus Butler
June, 2016

Sequencing of Therapy: A Case Based Presentation

Sponsored by Novartis

Unusual Complications of Immunotherapy

Featuring: Dr. Marcus Butler & Dr. Wilson Miller

Interactive Case-Based Discussion of Patients with High-Risk Melanomas

Sponsored by BMS

Microbiome and the Implications to Immunotherapy

Featuring: Dr. Karen Masden

Management and Treatment of Advanced Squamous Cell Carcinoma

Sponsored by Sanofi - Genzyme

Establishing Surveillance Guidelines for Stage 2 and Stage 3 Melanoma Patients

Featuring: Dr. Noelle Davis

Drug Funding Challenges

Featuring: Bill Dempster

Integrating New Treatment Options For Melanoma

Featuring:
Dr. Keith Flaherty

Diagnostic Advances in Melanoma Detection

Featuring:
Dr. Jason K. Rivers

A 7-yr Analysis of Mitotic Rate and Sentinel Lymph Node Biopsy

Featuring:
Dr. Heidi Wat

CheckMate 238 Trial

Featuring:
Dr. Jeffrey Weber

ABC Trial

Featuring:
Dr. Georgina Long

Adjuvant Therapy

Featuring:
Dr. Paul Lorigan

Melanoma

Featuring:
Dr. Wilson Miller

ASCO20 Virtual Data Watch - Melanoma

A multi-disciplinary approach to the evolving landscape of advanced cSCC

Featuring:
Dr. Scott Ernst
Dr. Ian Poon
Dr. Kathryn Roth
Dr. David Zloty

Melanoma

Featuring:
Dr. Parneet Cheema

Melanoma

Featuring:
Dr. Ralph Wong

COMBI-i Trial, LEAP-004 and SECOMBIT

Metastatic/Advanced Melanoma
Featuring:
Dr. Marcus Butler
Dr. Michael Smylie
Dr. Jason Luke

COMBI-AD & EORTC 1325-MG/KEYNOTE 054

Adjuvant Melanoma

Featuring:
Dr. Michael Smylie
Dr. Marcus Butler
Dr. Jason Luke

Symposium: Immunotherapy In Melanoma: Where Are We

Featuring:
Dr. Caroline Robert
Dr. Teresa Petrella
Dr. Michael Smylie

4-year recurrence-free and OS results from CheckMate 238

Featuring:
Dr. Jeffrey Weber